Based on 1 analysts giving stock ratings to Maia Biotechnology Inc in the past month.
In the current month, MAIA has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MAIA average Analyst price target in the last month is 12.000.
Based on analysts' estimates, MAIA EPS is projected to reach -0.130 in FY2026Q3, following reported EPS of -0.131 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.13, while Maia Biotechnology IncMAIA's earnings per share (EPS) for the previous quarter was USD -0.14. EPS for the next quarter is expected at USD -0.13.